Wave Life Sciences (WVE) Stock Surges Following Promising Trial Results
Tuesday’s closing price of $8.19 for Wave Life Sciences Ltd. (NASDAQ: WVE) experienced a strong 53.37% increase following the release of encouraging interim results from a clinical trial. Positive outcomes have been observed in the company’s current Phase 2 FORWARD-53 investigation of WVE-N531, an exon-skipping oligonucleotide intended to treat Duchenne muscular dystrophy (DMD). Dystrophin Expression …
Wave Life Sciences (WVE) Stock Surges Following Promising Trial Results Read More »